Across TCGA pan-cancer cohorts, LINC02247 RNA differs between tumor and matched normal tissue in 4 of 18 cancer types tested, making tumor–normal expression one of LINC02247’s most consistent transcriptional readouts.

The strongest signal is observed in breast invasive carcinoma (BRCA), where LINC02247 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types LINC02247 is over-expressed in tumor, although a few such as KICH show the opposite, repressed pattern.

BRCA, KICH, and LIHC are the cancer types where LINC02247 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in LINC02247 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
BRCA	Female	II,III,IV	+0.241	.001	4	view →
KICH	All	All	−0.057	.018	2	view →
LIHC	All	III,IV	+0.116	.034	1	view →
LUSC	All	All	+0.075	.032	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 4 strongest of 4 lineages.

Exploration

Same gene, other analysis: LINC02247 RNA expression & survival · all LINC02247 data types